secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001493152-24-041623
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American to delist Calidi Biotherapeutics warrants due to low trading price
--------------------------------------------------------------------------------

- NYSE Regulation commences delisting of Calidi warrants (CLDI WS) under Section 1001 of NYSE American Company Guide.
- Each warrant exercisable for 1/10th of a share at $115.00 per whole share; trading suspended immediately.
- Company has right to appeal to Listings Qualifications Panel; common stock (CLDI) remains listed on NYSE American.
- Delisting does not affect business operations or SEC reporting obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224041623/0001493152-24-041623-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224041623/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041623

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer